When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTVT - vTv Therapeutics to present full results from Phase 2 Simplici-T1 study of TTP399
vTv Therapeutics Inc.
VTv Therapeutics' (NASDAQ:VTVT) two late-breaking abstracts reinforcing the potential of TTP399 as an oral adjunctive therapy in type 1 diabetes will be presented at the American Diabetes Association’s 80th Scientific Sessions, which is being held virtually, June 12–16, 2020.
More news on: vTv Therapeutics Inc., Healthcare stocks news, Stocks on the move,